Risk
Factors
Introduction
Knowing about risk factors is important for
helping to identify women whose chances of developing
breast cancer are higher than average, and
to determine who may benefit from increased observation
or referrals to specialists. Similarly, women
with average risk can be helped to improve their chances
against developing
the disease by learning which lifestyle factors are
associated with increased risk and by modifying their
behaviors. In either case, it is important
that a woman's risk of breast cancer is routinely assessed
and that risk reduction strategies are
recommended.
Understanding
Risk
A risk factor is any characteristic or behavior that
increases the chances of developing a disease. Several
basic measures of risk may be used for describing a
woman's chances for developing breast cancer. The most
common measures are those of absolute and relative
risk.
Age-Specific
Probability
of Developing Breast Cancer |
If current
age is...
|
Probability of developing breast
cancer in next 10 years is: |
Or 1 in: |
| 30 |
0.44% |
229 |
| 40 |
1.46% |
68 |
| 50 |
2.73% |
37 |
| 60 |
3.82% |
26 |
Absolute Risk describes the percentage
chance that a person will develop a disease during
a given period of time. It is a useful measure for
helping to determine what proportion of the population
is at risk for a specific disease. In the case of breast
cancer, the most recent estimate of absolute risk during
the period of a lifetime is 13.32 percent, or roughly
1 in 8 women.1 However,
the absolute risk during any given decade of life
is lower. The accompanying table shows
the changes in absolute risk when estimating risk over
a 10 year
period for different age groups. Because rates of breast
cancer increase with age, age-specific estimates are
generally more meaningful than an estimate of lifetime
risk.2
Relative Risk describes the percentage
chance of developing a disease for persons having a
certain characteristic (or a behavior) compared with
those not having that same characteristic. Relative
risk is often expressed as a percentage (e.g., 50%
increase in risk). It is also often expressed as a
ratio, preceded by the abbreviation RR (e.g., RR 1.5).
RR 1.0 = no increase or decrease
in risk
RR 1.5 = 50% increase in risk
RR 2.0 = 100% increase in
risk
RR 0.5 = 50% decrease in risk
|
While familiar to most healthcare professionals, measures
of risk can be a source of confusion for patients.
In a study where women were asked to estimate their
risk of breast cancer, researchers found that 89 percent
overestimated their lifetime risk by more than three
times the actual risk (i.e., 46% vs. 13%).3 Overestimating
risk can cause undo stress and anxiety, both of which
can lead to an avoidance of screening and risk-reducing
strategies. When discussing risk with patients, healthcare
providers are encouraged to use the opportunity to
correct any potential misunderstanding. The use of
examples that compare expressions of relative risk
(e.g., 100% increase, or RR 2.0) with absolute risk
(2 in 100 vs. 1 in 100) may be helpful when reviewing
with patients the types of risk factors associated
with the development of breast cancer.
Types
of Risk Factors
With breast cancer, there are many established risk
factors, including those that cannot be modified, such
as family history, and those that can, like diet and
exercise. Different factors are associated with varying
increases in relative risk. Although a number of risk
factors for breast cancer have been identified, known
risk factors account for only a small percentage of
women who actually develop breast cancer.
Gender and Age: Female gender is
the most important risk factor for breast cancer. The
risk for females is 100 times that of males. The second
most important risk factor is age. The older a woman,
the greater her chances of developing the disease.
More than 80% of breast cancers occur in women aged
50 and older.4
Genetic Factors: Women with
an inherited BRCA1 or BRCA2 mutation have a greatly
increased risk of developing breast cancer. According
to The National Cancer Institute (NCI), estimates range
from 3 to 7 times that of women without these gene
mutations.5 While
BRCA1 and BRCA2 are the most common genes related to
hereditary breast cancer, other genes associated with
breast cancer risk include ATM, CHEK2, RAD51, AR, DIRAS3,
ERBB2, and TP53. Additional breast cancer susceptibility
genes that have not yet been identified are likely.6
Family History: Breast cancer
risk is increased for women having a first-degree biological
relative (mother, sister, daughter) or a second-degree
relative (grandmother, aunt, niece) with the disease.
Having one first-degree relative with breast cancer
approximately doubles a woman's risk; having two or
more first-degree relatives with breast cancer diagnosed
at an early age can increase risk by as much as 5-fold.7 In
general, the more biological relatives with breast
cancer, especially relatives who were diagnosed before
age 50, the higher a woman's breast cancer risk.
Personal History of Breast Cancer: A
personal history of breast cancer increases a woman's
risk of a second primary breast cancer either in the
opposite breast, or the same breast if there is remaining
tissue. The amount of risk depends on the presence
of other factors, such as a BRCA mutations. Likewise,
carcinoma in situ (LCIS and DCIS)
increases a woman's risk for developing invasive breast
cancer. Again, the magnitude of risk is modified by
other factors, such as menopausal status, family history,
time since biopsy, and treatment. Generally,
a woman with cancer in one breast has a 3- to 4-fold
increased risk of developing a new cancer in the opposite
breast or in another part of the same breast.8
Breast Density: Women with
mammographically dense breast tissue have an increased
risk of developing breast cancer. Studies using quantitative
methods for defining breast density report a 4 to 6
times increase in relative risk.9
Previous Breast Pathology: Women
with different types of noncancerous breast lesions
have different levels of relative risk of developing
subsequent breast cancer. Proliferative changes without
atypia are associated with an increased relative risk
of 1.5 to 2.0. Proliferative changes with atypia
affect a higher increase, ranging from 4.0 to 5.0. Additionally,
recent research suggests that nonproliferative changes
may be associated with a slight increase in relative
risk (RR 1.27).10
Previous Radiation Therapy: The
risk of breast cancer is significantly increased for
women who have had therapeutic radiation to the upper
torso (e.g., treatment of Hodgkin’s lymphoma).
Radiation treatment received at younger ages is associated
with higher risk. However, risk may be lowered for
patients who were also treated with chemotherapy and
the chemotherapy stopped ovarian hormone production.11
Hormonal Factors: The longer
a woman has been exposed to estrogen, the greater the
breast cancer risk. Estrogen exposure is increased
for women with early onset of menses (prior to age
12) and late menopause (after 55). Similarly, women
who have had no children or their first child after
age 30 have a slightly higher risk due to increased
estrogen exposure. Hormone replacement therapy is associated
with an increased risk of heart disease, heart attacks,
stroke, blood clots, and breast cancer.12 Findings
from studies of oral contraceptives have suggested
that risk is slightly increased for women who currently
use oral contraceptives, but risk may not be increased
for women who have stopped using them more than 10
years
ago.13
Weight and Diet: Obesity
is a risk factor for breast cancer, possibly associated
with higher levels of estrogen production. Excess fat
in the waist or upper body area, and weight gained
as an adult, especially near menopause, may increase
risk more than the same amount of fat in the hips and
thighs, or weight gained in childhood. With regard
to dietary fat, study findings have been inconclusive.14
Personal History of Other Cancers: The
risk of developing breast cancer is greater in women
who have been diagnosed with cancer of the endometrium,
ovary, or colon.15 The
association of other cancers with increased risk may
be due to genetic factors.
Alcohol: Alcohol consumption has
been shown to increase a woman's risk of breast cancer,
perhaps by raising the level of estrogen in the body.
Most studies suggest that the risk of breast cancer
increases as the amount of alcohol consumed increases.
One alcoholic drink a day confers only a slight increase
in risk while 2 to 5 drinks daily increases risk by
about 1.5 times.16
Race/Ethnicity/Socioeconomic Status: In
the U.S., breast cancer risk is highest for White women,
followed by African-American, Asian/Pacific Island
women, Hispanic women and lastly, American Indian and
Alaskan Native women. In general, women from lower
socioeconomic groups, regardless of their race/ethnicity,
have a lower risk of developing breast cancer but higher
death rates.17
DES: Women who took diethylstilbestrol
(DES), a synthetic form of estrogen hormone previously
prescribed to prevent miscarriage (from 1940 to 1971),
may have a slightly increased risk of breast cancer.18
Factors With Uncertain Effect on Breast
Cancer Risk
Smoking: Research on the relationship
between cigarette smoking and breast cancer risk has
produced mixed results. Some studies have found increased
risk (both for smokers and for passive smoke exposure)
while others have failed to establish an association.
In 2005, however, The California Environmental Protection
Agency concluded that the evidence regarding secondhand
smoke and breast cancer suggests a causal relationship
in younger, premenopausal women.19
Environmental Chemicals: Because
established risk factors for breast cancer account
for a minority of all cases, some believe that environmental
chemicals may play an important role in risk. Although
studies on humans have been inconclusive, the list
of chemicals known to cause breast tumors in laboratory
animals lends support to this position. Examples fall
within the categories of chemical solvents; chemicals
used with the manufacturing of dyes; chemicals used
in the manufacturing of rubber, vinyl, polyurethane
foams or neoprene; fumigants and pesticides; gasoline
additives; and pharmaceuticals, among others.20
Top
Risk
Assessment
|
Risk assessment for
breast cancer:
-
engages the primary care
provider and the patient in a discussion
about breast cancer prevention
-
educates a woman about risk
factors
-
helps guide a personalized
plan for risk reduction and early detection
|
Assessing a woman's individual risk for breast cancer
engages the primary care provider and the patient in
a discussion about breast cancer prevention, educates
a woman about risk factors, and helps guide a personalized
plan for risk reduction and early detection. A risk
assessment should be made at each routine screening
visit since a patient's personal risk factors will
change over time. The most frequently used models for
estimating breast cancer risk are the Gail and Claus
Models.
The Gail Model incorporates
a number of established risk factors to estimate a
woman's lifetime and 5-year risk for invasive breast
cancer. A 5-year risk of 1.7% or higher is considered
elevated and meets criteria for certain breast cancer
prevention trials. While an excellent assessment tool
for most patients, this model is not recommended for
use with patients having a strong family history since
it excludes some well-established factors associated
with hereditary breast cancer.21 The
Gail model is the basis for the Breast
Cancer Risk Assessment Tool available Online from
the National Cancer Institute.
The Claus Model provides
a more accurate estimate of risk for women with a family
history of breast cancer by taking into account both
maternal and paternal family history, second-degree
relatives, and their ages at diagnosis. It also factors
within the model a family history of ovarian cancer.
However, unlike the Gail Model, the Claus Model does
not include risk factors other than family history.22
In addition to these, The Assessment
of Risk Algorithm, developed by the State
of California, Department of Health Services, provides
a basic guide for primary care providers to follow
and can help identify women at greater risk of breast
cancer than the general population. The algorithm
attempts to incorporate risk factors that have epidemiologic
evidence of significant risk. It does not include
all possible risk factors nor does it assess absolute
risk for combinations of risk factors. In summary,
the algorithm provides a qualitative assessment of
risk based on personal history, family history, medical/pathological/genetic
factors, with the outcome of either normal or increased
risk for breast cancer. The Assessment
of Risk Algorithm is available on this web site.
A complete breast cancer risk assessment includes
an evaluation for known risk factors using a reliable
risk assessment tool and obtaining a thorough personal
and family history. The Breast
Cancer History and Risk Assessment Form, also developed
by the California Department of Health Services, can
be used with the Assessment
of Risk Algorithm to help identify women who may
be at increased risk of developing breast cancer. For
the woman with high risk, a referral to a risk assessment
counselor can be helpful in further defining her risk,
identifying possible genetic risks, and recommending
appropriate risk reduction strategies.
Top
Gene
Testing
|
According to
The National Cancer Institute, women with an
altered BRCA1 or BRCA2 gene are 3 to 7 times
more likely to develop
breast cancer than women without
alterations in these genes.
|
Inherited breast cancer accounts for 5% to 10% of
all breast cancers.23 Of
these, only a small percent of cases will be linked
to BRCA1 and BRCA2 mutations. Even among women with
these mutations, not all will develop breast cancer.
For this reason, The U.S. Preventive Services Task
Force cautions against routine testing for genetic
risk of breast cancer. However, if a patient's family
history is strongly suggestive of BRCA mutations, the
Task Force recommends that her primary care physician
suggest genetic counseling and possible gene testing.24
For helping to identify patients with increased risk
for BRCA mutations, the Mayo Clinic lists the following: 25
- A history of breast cancer in two or more first-degree
relatives
- Onset of breast cancer before age 50 in family
members (maternal or paternal)
- A history of breast cancer in more than one generation
- A male relative with breast cancer
- A family member who has both breast and ovarian
cancers
- Breast cancer in both breasts of a family member
- A frequent occurrence of ovarian cancer within
the family
- A positive BRCA1 or BRCA2 genetic test in a relative
- Ashkenazi (Eastern European) Jewish ancestry,
with or without a family history of breast or ovarian
cancer
According to The National Cancer Institute, women
with an altered BRCA1 or BRCA2 gene are 3 to 7 times
more likely to develop breast cancer than women without
alterations in these genes.26 In
addition, these women have an increased risk of ovarian
cancer, and of developing these cancers at a young
age (i.e., before menopause). It is therefore essential
that women with these gene mutations be identified
and referred for thorough evaluation. If gene testing
is indicated, the genetic counselor will advise the
woman of the benefits, limitations, and risks of testing
- including those that have potential impact for a
woman's emotions, social relationships, finances and
employment. If gene testing is not indicated, or if
the patient chooses not to be tested, she should
nevertheless be provided with a thorough cancer risk
management plan.
Professionals who provide services related to cancer
genetics (cancer risk assessment, genetic counseling,
genetic susceptibility testing, and others) can be
located using NCI's Cancer
Genetics Services Directory. A genetic counselor
can also be located through the The
National Society of Genetic Counselors web site.
Genetic tests may be ordered by the genetic counselor
or by the primary care provider. GeneTests,
an NIH-funded educational project to help healthcare
providers understand the appropriate use of genetic
counseling and testing, is an excellent Online source
for learning more about this topic. Additionally, the National
Human Genome Research Institute (NHGRI) offers
a thorough review of related ethical, policy and legislative
issues.
Top
Risk
Reduction Strategies
Risk reduction strategies should be
tailored to each woman's level of risk, balance of
risk and benefits, and personal preference.
Strategies for Women at Average
Risk
For women at average risk, the emphasis
is on healthy lifestyle habits. The American Cancer
Society recommends that women avoid alcohol, exercise
regularly, and maintain a healthy body weight. Women
who give birth to several children might wish to
consider breast-feeding for longer periods (reduces
number of lifetime menstrual cycles). Avoiding hormone
replacement therapy after menopause will keep a woman
from increasing her risk. Low-fat diets may also
help to reduce risk, although study findings on the
relationship between dietary fat and breast cancer
are inconclusive. At minimum, a low-fat diet can
help to reduce risk indirectly by helping to prevent
obesity - one of the established risk factors for
breast cancer. Likewise, patients wishing to decrease
their risk of breast cancer should avoid smoking.
While the research in this area is inconclusive,
most recent studies appear to suggest a linkage.
Patients who modify
their lifestyle choices toward reducing their
risk of breast cancer will be taking constructive
steps toward better overall health. But even with
best efforts, changes in modifiable risk factors
still leave a woman vulnerable. Other than behavioral
changes, the most important action a woman can take
to decrease her chances of dying from breast cancer
is to follow early detection guidelines. The earlier
breast cancer is found, the better the chances for
successful treatment.
Strategies for Women at Increased
Risk
For women at increased risk, additional
risk reduction strategies should be considered. At
present, these strategies include increased surveillance;
the use of additional imaging tests; chemoprevention
(e.g., tamoxifen); and, for women with a strong family
history or known genetic predisposition, prophylactic
mastectomy. Enrollment in a breast cancer prevention
trial may also be considered for women with higher
than average risk. For more information about this
topic, healthcare providers are referred to the National
Comprehensive Cancer Network (NCCN) web site.
NCCN's Clinical
Practice Guidelines in Oncology™ are a
recognized standard for clinical policy in the oncology
community.
Top
Notes
1National
Cancer Institute. Probability of Breast Cancer
in American Women (Apr. 15, 2005). Retrieved
Jul. 9, 2006 at: http://www.cancer.gov/cancertopics/factsheet/Detection/probability-
breast-cancer
2See
note 1.
3Behind
the Cancer Headlines. Women
Overestimate Breast Cancer Risk (Jun. 7,
2005). Retrieved Apr. 2, 2006 at: http://www.mabcie.com/June_7,_2005_breast_cancer.html
4MedlinePlus. Breast
Cancer (updated, Oct. 21, 2005). Retrieved
Jul. 9, 2006 at: http://www.nlm.nih.gov/medlineplus/ency/article/000913.htm
5National
Cancer Institute. Genetic Testing for BRCA1
and BRCA2: It's Your Choice (Feb. 6, 2002).
Retrieved Jul. 9, 2006 at: http://www.cancer.gov/cancertopics/factsheet/Risk/BRCA
6Genetics
Home Reference. Breast Cancer (May,
2006). Retrieved Jul. 9, 2006 at: http://ghr.nlm.nih.gov/condition=breastcancer
7American
Cancer Society. What
Are the Risk Factors for Breast Cancer? (revised,
Sep. 2, 2005). Retrieved Apr. 9, 2006 at: http://www.cancer.org/docroot/CRI/content/CRI_2_4_2X_
What_are_ the_risk_ factors_for_ breast_cancer_5.asp
8See
note 7.
9Korde
LA, Calzone KA, Zujewski J. Assessing
Breast Cancer Risk: Genetic Factors Are Not the
Whole Story. Postgrad Med. 2004 Oct;116(4):6-8,
11-4, 19-20. Retrieved Apr. 13, 2006 at: http://www.postgradmed.com/issues/2004/10_04/korde.htm
10National
Cancer Institute. Benign
Breast Disease Indicates Relative Risk for Breast
Cancer. NCI Bulletin. 2005 Jul;30(2). Retrieved
Apr. 13, 2006 at:http://www.cancer.gov/ncicancerbulletin/
NCI_Cancer_Bulletin_072605/page5
11See
note 7.
12MedlinePlus. Hormone
Replacement Therapy (updated, Feb. 9, 2006).
Retrieved Jul. 9, 2006 at: http://www.nlm.nih.gov/medlineplus/ency/article/007111.htm
13See
note 7.
14See
note 7.
15Fletcher,
SW. Risk Factors for Breast Cancer (May 11, 2006).
Retrieved Jul. 9, 2006 at: http://patients.uptodate.com/topic.asp?title=breast+cancer+reduction&file=cancer/2174&
mark=1&submit=find
16See
note 7.
17The
Program on Breast Cancer Environmental Factors. Fact
Sheet #47: Breast Cancer in Women from Different
Racial/Ethnic Groups (Apr., 2003). Retrieved
Apr. 13, 2006 at: http://envirocancer.cornell.edu
/Factsheet/general/fs47. ethnicity.cfm
18See
note 7.
19See
note 7.
20The
Program on Breast Cancer Environmental Factors. Fact
Sheet #45: Environmental Chemicals and Breast Cancer
Risk Why is There Concern? (May, 2002). Retrieved
Apr. 13, 2006 at: http://envirocancer
.cornell.edu/factsheet/general/fs45.chemical.cfm
21National
Cancer Institute. Models
for Prediction of Breast Cancer Risk (last
modified, Mar. 24, 2006). Retrieved Apr. 10, 2006
at: http://cancernet.nci.nih.gov/cancertopics/pdq/genetics/breast
-and-ovarian/healthprofessional#Section_66
22See
note 21.
23See
note 5.
24National
Human Genome Research Institute.Task
Force Recommends Against Routine Testing for Genetic
Risk of Breast or Ovarian Cancer in the General Population (Sept,
2005). Retrieved Apr. 10, 2006 at: http://www.genome.gov/16015415
25Mayo
Clinic. Genetic
testing for breast and ovarian cancers: When family
history places you at high risk (Jan. 24,
2005). Retrieved Jul. 9, 2006 at: http://www.mayoclinic.com/health/genetic-testing-
for-breast-cancer/HQ00350
26See
note 5.
All external links are provided
as a service to our visitors for information purposes
only. No endorsement is made or implied.
Revised: November 30, 2007.
|